Jubilant Life Sciences - 3QFY2013 Result Review - Nirmal Bang

- Result in-line with expectations

- Sales grew by 19% yoy to Rs 1306 cr

- EBITDA grew by 24.5% to Rs 260 cr with 80 bps improvement in margins

Source : Equity Bulls

Keywords